Doximity valuation
$27.78Change from previous close: −0.04%Absolute change: −$0.01
Valuation
The P/E ratio is 32.7. The average price target of 18 analysts is $29.67.
Data as of October 7, 2026
Valuation multiples
- Market cap
- $4.95B
- Enterprise value
- $4.28B
- P/E (trailing 12 months)
- 32.7
- Forward P/E
- 17.8
- PEG
- 0.59
- Price/book
- 5.46
- Price/sales
- 7.56
- EV/EBITDA
- 20.5
- EV/revenue
- 6.52
Profitability and growth
- Gross margin
- 88.1%
- Operating margin
- 21.5%
- Net margin
- 25.5%
- ROE
- 17.2%
- ROA
- 10.9%
- ROIC
- 65.7%
- Revenue growth (year over year)
- 7.3%
- Earnings growth (year over year)
- -51.9%
Financial health
- Total cash
- $687.79M
- Total debt
- $9.67M
- Debt/equity
- 0.01
- Current ratio
- 6.08
- Quick ratio
- 5.80
- Altman Z-Score
- 31.3
- Piotroski F-Score
- 5.00
Dividends
- Dividend yield
- 0.0%
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $29.67
- Median price target
- $28.00
- High price target
- $47.00
- Low price target
- $18.00
- Analysts with a price target
- 18
- Consensus
- Hold
- Forward EPS
- $1.56
- EPS estimate, current year
- $1.35
Shares and trading
- Beta
- 1.22
- Average volume
- 4.43M
- Shares outstanding
- 127.35M
- Float
- 123.64M
- Institutional ownership
- 102.3%
- Insider ownership
- 3.0%
- Short interest (% of float)
- 9.9%
- Short ratio (days)
- 4.63